Stability Studies for Primary vs. Secondary Pharmaceutical Packaging
Stability Studies for Primary vs. Secondary Pharmaceutical Packaging
Stability Studies for Primary vs. Secondary Pharmaceutical Packaging
Container Closure Integrity Testing in Biologic Stability Studies Ensuring Sterility and Stability: Container Closure Integrity Testing for Biologics Container Closure Integrity Testing (CCIT) is an essential part of biopharmaceutical product development, ensuring that the packaging system maintains its barrier properties throughout the product’s shelf life. For sterile biologic products—particularly parenterals—container closure integrity (CCI) directly impacts…
Read More “Container Closure Integrity Testing in Biologic Stability Studies” »
Re-Test Period vs. Shelf Life in Pharmaceutical Stability Studies Re-Test Period vs. Shelf Life in Pharmaceutical Stability: Key Distinctions and Regulatory Insights Introduction In pharmaceutical development and GMP manufacturing, the concepts of re-test period and shelf life serve different but equally critical functions. Confusion between the two can lead to regulatory noncompliance, improper material usage,…
Read More “Re-Test Period vs. Shelf Life in Pharmaceutical Stability Studies” »
Comparing ICH and ISO Standards for Stability Testing in Non-Pharma Sectors ICH vs. ISO Stability Testing Standards in Non-Pharmaceutical Sectors Introduction Stability testing is a critical element of quality assurance in many regulated industries. While the International Council for Harmonisation (ICH) sets the gold standard for pharmaceutical stability testing, other sectors like food, cosmetics, nutraceuticals,…
Read More “Comparing ICH and ISO Standards for Stability Testing in Non-Pharma Sectors” »
Understanding the Tip: What is DoE in the context of stability studies: Design of Experiments (DoE) is a structured, statistical approach to determine the relationship between input factors and measured responses. In early-stage stability studies, DoE allows scientists to systematically explore how variables such as temperature, humidity, packaging type, and formulation composition affect product stability….
Read More “Leverage Design of Experiments (DoE) in Early Stability Study Planning” »
EMA Stability Guidelines for the European Union: Comprehensive Regulatory Framework EMA Stability Guidelines for the European Union: Comprehensive Regulatory Framework Introduction The European Medicines Agency (EMA) is responsible for the scientific evaluation, supervision, and safety monitoring of medicines in the European Union (EU). As part of its mandate, the EMA enforces rigorous stability testing standards…
Read More “EMA Stability Guidelines for the European Union: Comprehensive Regulatory Framework” »
SOP for Developing Stability Study Reports for ANDA Submissions Guidelines for Stability Study Reports for ANDA Submissions 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for preparing stability study reports for Abbreviated New Drug Application (ANDA) submissions to the United States Food and Drug Administration (US FDA). This SOP…
Read More “SOP for Developing Stability Study Reports for ANDA Submissions” »
Photostability Testing of Biopharmaceutical Products Photostability Testing Strategies for Biopharmaceutical Products Photostability testing is an essential component of the overall stability strategy for biopharmaceutical products, especially those sensitive to ultraviolet (UV) or visible light exposure. Light-induced degradation can lead to loss of potency, structural damage, or formation of immunogenic species. Regulatory guidelines such as ICH…
Read More “Photostability Testing of Biopharmaceutical Products” »
Role of Packaging in Preventing Drug Degradation and Ensuring Stability How Pharmaceutical Packaging Prevents Drug Degradation and Extends Shelf Life Introduction Packaging plays a pivotal role in the pharmaceutical industry—not only as a container for marketing and logistics but as a scientifically engineered system to preserve the drug’s potency, purity, and safety. Drug degradation is…
Read More “Role of Packaging in Preventing Drug Degradation and Ensuring Stability” »
Implementing ICH Q1A in Freeze-Thaw Study Design Designing Freeze-Thaw Studies According to ICH Q1A Guidelines The International Council for Harmonisation (ICH) Q1A(R2) guideline is the global reference for stability testing of new drug substances and products. While the guideline focuses primarily on long-term, intermediate, and accelerated stability conditions, its principles also guide the design of…
Read More “Implementing ICH Q1A in Freeze-Thaw Study Design” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.
